VASCONCELLES MICHAEL — SEC insider filings

SEC reporting owner CIK 1734755. 14 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2022-08-17 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Day One Biopharmaceuticals, Inc. (DAWN)Head of Research and Dev.4—1 leg · 2,728 sh · $31,64711
ImmunoGen, Inc. (IMGN)EVP R&D & MEDICAL AFFAIRS4——6
Kura Oncology, Inc. (KURA)Director3——4
MACROGENICS INC (MGNX)Director2——2
Magenta Therapeutics, Inc. (MGTA)Director1——1

Insider filings — VASCONCELLES MICHAEL

FiledFormIssuerReported transactionsSource
2026-11-034MACROGENICS INC (MGNX)Grant/award (A): 44,000 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2026-11-033MACROGENICS INC (MGNX)Holdings only — no transactions reportedEDGAR
2026-06-044Kura Oncology, Inc. (KURA)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2026-04-234Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 4,397 · Disposition to issuer (D): 346,000 (derivative) · Disposition to issuer (D): 171,000 (derivative) · Disposition to issuer (D): 226,000 (derivative) · Disposition to issuer (D): 106,875 (derivative)EDGAR
2026-02-184Day One Biopharmaceuticals, Inc. (DAWN)Option exercise (M): 7,125 · Sale (S): 2,728 @ $11.60 · Option exercise (M): 7,125 (derivative) @ $0EDGAR
2026-01-304Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 171,000 (derivative) @ $0 · Grant/award (A): 114,000 (derivative) @ $0EDGAR
2025-06-184Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 346,000 (derivative) @ $0 · Grant/award (A): 226,000 (derivative) @ $0EDGAR
2025-06-064Kura Oncology, Inc. (KURA)Grant/award (A): 28,500 (derivative) @ $0EDGAR
2024-09-174Kura Oncology, Inc. (KURA)Grant/award (A): 52,000 (derivative) @ $0 · Grant/award (A): 17,333 (derivative) @ $0EDGAR
2024-02-124ImmunoGen, Inc. (IMGN)Disposition to issuer (D): 1,327 · Disposition to issuer (D): 960,000 (derivative) · Disposition to issuer (D): 50,515 (derivative)EDGAR
2024-02-054ImmunoGen, Inc. (IMGN)Grant/award (A): 50,515 (derivative) @ $0EDGAR
2024-01-034ImmunoGen, Inc. (IMGN)Grant/award (A): 1,327 @ $16.01EDGAR
2023-01-034ImmunoGen, Inc. (IMGN)Grant/award (A): 960,000 (derivative) @ $0EDGAR
2022-08-174Magenta Therapeutics, Inc. (MGTA)Grant/award (A): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734755 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs